Rob Dillard

DocwireNews

<h2>Moderna Vaccine Beats out Pfizer and J&amp;J in Efficacy<p>According to the findings of a head-to-head study of all three authorized COVID-19 vaccines in the U.S., the Moderna vaccine is slightly more effective than Pfizer&rsquo;s at keeping people out of the hospital. Moderna&rsquo;s vaccine provided 93% protection as the SARS-CoV-2 virus, while Pfizer&rsquo;s vaccine was 88%. Johnson &amp; Johnson&rsquo;s one shot vaccine is is considerably lower, but still effective, at 71%.</p><p>&ldquo;Among U.S. adults without immunocompromising conditions, vaccine effectiveness against COVID-19 hospitalization during March 11&ndash;August 15, 2021, was higher for the Moderna vaccine (93%) than the Pfizer-BioNTech vaccine (88%) and the Janssen vaccine (71%),&rdquo; the team wrote in the CDC&rsquo;s weekly report on death and disease, the MMWR, <a href="https://www.cnn.com/2021/09/17/health/moderna-vaccine-most-effective-cdc-study/index.html">via a</a> CNN report.</p><h2><a href="https://www.docwirenews.com/docwire-pick/hospitalizing-the-unvaccinated-has-cost-u-s-nearly-6-billion/">Hospitalizing the Unvaccinated is Extremely Costly&nbsp;</a></h2><p>The cost of providing hospital care for unvaccinated Americans has reached $5.7 billion in just three months,&nbsp;<em>CBS News</em> reported. In the&nbsp;<a href="https://www.healthsystemtracker.org/brief/unvaccinated-covid-patients-cost-the-u-s-health-system-billions-of-dollars/" target="_blank" rel="noopener noreferrer">new report,</a> the KFF-Peterson team used data from the U.S. Centers for Medicare and Medicaid Services to estimate the average cost of hospitalization with COVID-19 at $20,000 per person. They then calculated the overall expense at $5.7 billion. &ldquo;This ballpark figure is likely an understatement of the cost burden from preventable treatment of COVID-19 among unvaccinated adults,&rdquo; the authors wrote, noting that the study doesn&rsquo;t account for outpatient costs.</p><h2>COVID-19 Booster Doses Have Similar Safety Profiles as First Two Doses</h2><p>The findings of a study from Israel suggest that COVID-19 booster doses do not appear to have additional events or safety concerns compared to the first two doses of the vaccine. &ldquo;We didn&rsquo;t see any new types of adverse events and the rate, to be modest, is at least the same if not lower,&rdquo;&nbsp;Dr. Sharon Elroy-Preiss, director of public health services at Israel&rsquo;s Ministry of Health, told the US Food and Drug Administration&rsquo;s&nbsp;Vaccines and Related Biological Products Advisory Committee (VRBPAC)&nbsp;in a meeting Friday, <a href="https://www.cnn.com/world/live-news/coronavirus-vaccine-booster-news-09-17-21/index.html">per a</a> CNN report.</p><h2><a href="https://www.docwirenews.com/home-page-editor-picks/covid-19-school-closures-take-toll-on-mental-health-of-older-children/">COVID School Closures Take Mental Toll on Older Children</a></h2><p>Older children, Black and Hispanic children, and children from families with lower income who attended school remotely during the pandemic in 2020 experienced disproportionate mental health difficulties, according to a study published online &shy;Sept. 3 in&nbsp;<em>JAMA Network Open</em>. The analysis included survey responses collected between Dec. 2 and Dec. 21, 2020, from 2,324 U.S. adults with at least one school-aged child living in their household. &ldquo;These findings suggest that allocating funding to support safe in-person instruction may reduce mental health inequities associated with race/ethnicity and income,&rdquo; the authors write.</p></h2>


Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Jordana Jampel

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Eric Bergson, MD

The Role of Multidisciplinary Care in Head and Neck Cancer

Head and Neck Cancer

Latest News

COVID-19 Round-Up: Moderna Vaccine Most Effective, Hospitalizing the Unvaxxed is Costly; and More

COVID-19

Moderna Vaccine Beats out Pfizer and J&amp;J in Efficacy ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe